Ticker Details
Recursion Pharmaceuticals, Inc.
IPO Date:	April 16, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.75B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.40 | 3.83%
Avg Daily Range (30 D):	$0.07 | 2.19%
Avg Daily Range (90 D):	$0.12 | 2.96%

Institutional Daily Volume
Avg Daily Volume:	8.59M
Avg Daily Volume (30 D):	11.89M
Avg Daily Volume (90 D):	17.59M

Trade Size
Avg Trade Size (Sh.):	241
Avg Trade Size (Sh.) (30 D):	296
Avg Trade Size (Sh.) (90 D):	335

Institutional Trades
Total Institutional Trades:	2,800
Avg Institutional Trade:	$2.27M
Avg Institutional Trade (30 D):	$2.53M
Avg Institutional Trade (90 D):	$2.39M
Avg Institutional Trade Volume:	.31M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.94M
Avg Closing Trade (30 D):	$4.1M
Avg Closing Trade (90 D):	$4.55M
Avg Closing Volume:	545.03K

News

Mar 31, 2026 @ 1:00 PM Recursion Expands Strategic Partnership with Citel... Source: Na

Mar 22, 2026 @ 5:27 PM Prediction: The "Trough of Disillusionment" Will C... Source: James Brumley

Feb 24, 2026 @ 8:52 PM ARK Unplugged: How Cathie Wood Crushed the S&P 500... Source: Erica Kollmann

Feb 22, 2026 @ 3:02 PM Cathie Wood Goes Bargain Hunting: 3 Stocks She Jus... Source: Rick Munarriz

Jan 29, 2026 @ 2:01 AM Can This Beaten-Down AI Stock Bounce Back in 2026?... Source: Prosper Junior Bakiny

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.44	$-.17	$-1.44
Diluted EPS	$-1.44	$-.17	$-1.44
Revenue	$74.68M	$35.54M	$74.68M
Gross Profit	$3.73M	$21.26M	$3.73M
Net Income / Loss	$-644.76M	$-108.12M	$-644.76M
Operating Income / Loss	$-648.13M	$-108.33M	$-648.13M
Cost of Revenue	$70.95M	$14.28M	$70.95M
Net Cash Flow	$150.9M	$86.78M	$150.9M
PE Ratio